Tarceva and Pepcid drug interactions - from FDA reports


Summary

Drug interactions are reported among people who take Tarceva and Pepcid together. This review analyzes the effectiveness and drug interactions between Tarceva and Pepcid. It is created by eHealthMe based on reports of 401 people who take the same drugs from FDA, and is updated regularly.

What to expect?

If you take Tarceva and Pepcid, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Tarceva and Pepcid

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Tarceva

Tarceva has active ingredients of erlotinib hydrochloride. It is often used in lung cancer. (latest outcomes from Tarceva 19,244 users)

Pepcid

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. (latest outcomes from Pepcid 28,480 users)

On Feb, 09, 2017

401 people who take Tarceva, Pepcid are studied.


Number of reports submitted per year:

Tarceva and Pepcid drug interactions.

Most common drug interactions over time *:

< 1 month:
  • malignant neoplasm progression
  • diarrhoea
  • dermatitis acneiform
  • decreased appetite
  • rash
  • anaemia
  • pyrexia
  • platelet count decreased
  • interstitial lung disease
  • neoplasm malignant
1 - 6 months:
  • anaemia
  • dermatitis acneiform
  • malignant neoplasm progression
  • diarrhoea
  • paronychia
  • rash
  • neoplasm malignant
  • death
  • decreased appetite
  • insomnia
6 - 12 months:
  • pneumonia
  • deep vein thrombosis
  • asthenia
  • decreased appetite
  • rash
  • cardiac arrest
  • death
  • hyponatraemia
  • small intestinal obstruction
  • supraventricular tachycardia
1 - 2 years:
  • gout
  • hiccups
  • irritable bowel syndrome
  • atelectasis
  • hypotension
  • tachycardia
  • rash
  • bronchitis
  • constipation
  • gastritis
2 - 5 years:
  • cardiopulmonary failure
  • vomiting
  • focal segmental glomerulosclerosis
not specified:
  • death
  • rash
  • fatigue
  • diarrhoea
  • malignant neoplasm progression
  • decreased appetite
  • pneumonia
  • pain
  • asthenia
  • dyspnoea

Most common drug interactions by gender *:

female:
  • death
  • fatigue
  • rash
  • malignant neoplasm progression
  • decreased appetite
  • diarrhoea
  • anaemia
  • pneumonia
  • asthenia
  • headache
male:
  • death
  • diarrhoea
  • rash
  • malignant neoplasm progression
  • pneumonia
  • decreased appetite
  • fatigue
  • dyspnoea
  • nausea
  • pyrexia

Most common drug interactions by age *:

30-39:
  • malignant neoplasm progression
  • rash
  • dermatitis acneiform
  • akathisia
  • aspartate aminotransferase increased
  • blood alkaline phosphatase increased
  • blood creatinine increased
  • catheter site pain
  • constipation
  • decreased appetite
40-49:
  • death
  • hypophagia
  • abdominal pain
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • gastrointestinal haemorrhage
  • general physical health deterioration
  • hypoalbuminaemia
  • nausea
  • dermatitis acneiform
50-59:
  • decreased appetite
  • anaemia
  • neoplasm malignant
  • diarrhoea
  • fatigue
  • death
  • pulmonary embolism
  • insomnia
  • rash
  • malignant neoplasm progression
60+:
  • rash
  • death
  • malignant neoplasm progression
  • diarrhoea
  • fatigue
  • pneumonia
  • decreased appetite
  • interstitial lung disease
  • nausea
  • hepatic function abnormal

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Tarceva and Pepcid?

Interactions between Tarceva and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

Interactions between Pepcid and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Tarceva (erlotinib hydrochloride) is often used to treat lung neoplasm malignant. Pepcid (famotidine) is often used to treat gastrooesophageal reflux disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:

Can you answer these questions?

More questions for: Tarceva, Pepcid

You may be interested in these reviews

More reviews for: Tarceva, Pepcid